Pace, Joshua
Lee, Jane J.
Srinivasarao, Madduri
Kallepu, Shivakrishna
Low, Philip S.
Niedre, Mark http://orcid.org/0000-0002-1318-0173
Funding for this research was provided by:
National Cancer Institute (R21CA246413)
Northeastern University USA
Article History
Received: 12 December 2023
Revised: 4 March 2024
Accepted: 30 March 2024
First Online: 9 April 2024
Declarations
:
: All mice were handled in accordance with Northeastern University’s Institutional Animal Care and Use Committee (IACUC) policies on animal care. Animal experiments were carried out under Northeastern University IACUC protocol #21-0412R. All experiments and methods were performed with approval from and in accordance with relevant guidelines and regulations of Northeastern University IACUC.
: Philip S. Low is on the Board of Directors for On Target Laboratories Inc., manufacturer of EC17 and OTL38.